Zeitschriftenartikel zum Thema „Myeloid leukemia“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Myeloid leukemia" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Swatler, Julian, Laura Turos-Korgul, Ewa Kozlowska und Katarzyna Piwocka. „Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias“. Cancers 13, Nr. 6 (10.03.2021): 1203. http://dx.doi.org/10.3390/cancers13061203.
Namikawa, R., R. Ueda und S. Kyoizumi. „Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice“. Blood 82, Nr. 8 (15.10.1993): 2526–36. http://dx.doi.org/10.1182/blood.v82.8.2526.2526.
Namikawa, R., R. Ueda und S. Kyoizumi. „Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice“. Blood 82, Nr. 8 (15.10.1993): 2526–36. http://dx.doi.org/10.1182/blood.v82.8.2526.bloodjournal8282526.
Aue, Georg, Yang Du, Susan M. Cleveland, Stephen B. Smith, Utpal P. Davé, Delong Liu, Marc A. Weniger et al. „Sox4 cooperates with PU.1 haploinsufficiency in murine myeloid leukemia“. Blood 118, Nr. 17 (27.10.2011): 4674–81. http://dx.doi.org/10.1182/blood-2011-04-351528.
Shvachko, L. P. „EMT-mechanizm induces the leukemic stemness phenotype in myeloid leukemias“. Faktori eksperimental'noi evolucii organizmiv 23 (09.09.2018): 256–60. http://dx.doi.org/10.7124/feeo.v23.1024.
Jamieson, Catriona, Sidd Jaiswal, David Traver, Jason Gotlib, Mark Chao und Irving L. Weissman. „Increased Expression of CD47 Is a Constant Marker in Mouse and Human Myeloid Leukemias.“ Blood 106, Nr. 11 (16.11.2005): 3260. http://dx.doi.org/10.1182/blood.v106.11.3260.3260.
ENACHE, Tatiana Cristina, Ana-Maria VLĂDĂREANU, Horia BUMBEA, Minodora ONISÂI und Ion DUMITRU. „EPIDEMIOLOGICAL AND IMMUNOPHENOTYPIC CHARACTERIZATION OF ACUTE MYELOID LEUKEMIAS“. Romanian Journal of Medical Practice 12, Nr. 4 (31.12.2017): 234–39. http://dx.doi.org/10.37897/rjmp.2017.4.11.
Войцеховский, Валерий, Valeriy Voytsekhovskiy, Татьяна Заболотских, Tat'yana Zabolotskikh, Алексей Григоренко, Aleksey Grigorenko, Екатерина Филатова und Ekaterina Filatova. „DAMAGE OF THE BRONCHOPULMONARY SYSTEM IN PATIENTS WITH CHRONIC HEMOBLASTOSIS“. Bulletin physiology and pathology of respiration 1, Nr. 69 (05.10.2018): 25–35. http://dx.doi.org/10.12737/article_5b975083a62278.59044240.
Padmanabhan, Dr K. „An Interesting Case of Acute Myeloid Leukemia“. Journal of Medical Science And clinical Research 05, Nr. 02 (28.02.2017): 18166–68. http://dx.doi.org/10.18535/jmscr/v5i2.150.
Jones, Letetia, Sabina Sevcikova, Vernon Phan, Sachi Jain, Angell Shieh, Joshua Dubansky, Min Li et al. „Myc Drives Chromosomal Gain in Acute Myeloid Leukemia“. Blood 112, Nr. 11 (16.11.2008): 792. http://dx.doi.org/10.1182/blood.v112.11.792.792.
Longo, Giuseppe S. A., Richard Gorlick, William P. Tong, Emine Ercikan und Joseph R. Bertino. „Disparate Affinities of Antifolates for Folylpolyglutamate Synthetase From Human Leukemia Cells“. Blood 90, Nr. 3 (01.08.1997): 1241–45. http://dx.doi.org/10.1182/blood.v90.3.1241.
Longo, Giuseppe S. A., Richard Gorlick, William P. Tong, Emine Ercikan und Joseph R. Bertino. „Disparate Affinities of Antifolates for Folylpolyglutamate Synthetase From Human Leukemia Cells“. Blood 90, Nr. 3 (01.08.1997): 1241–45. http://dx.doi.org/10.1182/blood.v90.3.1241.1241_1241_1245.
Swatler, Julian, Laura Turos-Korgul, Marta Brewinska-Olchowik, Sara De Biasi, Wioleta Dudka, Bac Viet Le, Agata Kominek et al. „4-1BBL–containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells“. Blood Advances 6, Nr. 6 (17.03.2022): 1879–94. http://dx.doi.org/10.1182/bloodadvances.2021006195.
Pietsch, T., U. Kyas, U. Steffens, E. Yakisan, MR Hadam, WD Ludwig, K. Zsebo und K. Welte. „Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors“. Blood 80, Nr. 5 (01.09.1992): 1199–206. http://dx.doi.org/10.1182/blood.v80.5.1199.1199.
Pietsch, T., U. Kyas, U. Steffens, E. Yakisan, MR Hadam, WD Ludwig, K. Zsebo und K. Welte. „Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: heterogeneity in response and synergy with other hematopoietic growth factors“. Blood 80, Nr. 5 (01.09.1992): 1199–206. http://dx.doi.org/10.1182/blood.v80.5.1199.bloodjournal8051199.
Takimoto, Rishu, Junji Kato, Koichi Takada, Takuya Matsunaga und Yoshiro Niitsu. „Impaired Expression of the DNA Repair Factor DDB2 in Human Myeloid Leukemias.“ Blood 104, Nr. 11 (16.11.2004): 2046. http://dx.doi.org/10.1182/blood.v104.11.2046.2046.
Narayanan, Geetha, M. T. Sugeeth und Lali V. Soman. „Mixed Phenotype Acute Leukemia Presenting as Leukemia Cutis“. Case Reports in Medicine 2016 (2016): 1–3. http://dx.doi.org/10.1155/2016/1298375.
Alten, Florian, Karoline Ehlert, Michael R. Böhm und Ulrike H. Grenzebach. „Leukemic Hypopyon in Acute Myeloid Leukemia“. European Journal of Ophthalmology 23, Nr. 2 (März 2013): 252–54. http://dx.doi.org/10.5301/ejo.5000177.
Shirazi, Nadia, Akriti Saxena, Kunal Das und Vikas Shrivastava. „Small-Bowel Myeloid Sarcoma Presenting as A Relapse Case of Acute Myeloid Leukemia“. Annals of Pathology and Laboratory Medicine 5, Nr. 7 (29.07.2018): C107–110. http://dx.doi.org/10.21276/apalm.1876.
Dinndorf, PA, RG Andrews, D. Benjamin, D. Ridgway, L. Wolff und ID Bernstein. „Expression of normal myeloid-associated antigens by acute leukemia cells“. Blood 67, Nr. 4 (01.04.1986): 1048–53. http://dx.doi.org/10.1182/blood.v67.4.1048.1048.
Dinndorf, PA, RG Andrews, D. Benjamin, D. Ridgway, L. Wolff und ID Bernstein. „Expression of normal myeloid-associated antigens by acute leukemia cells“. Blood 67, Nr. 4 (01.04.1986): 1048–53. http://dx.doi.org/10.1182/blood.v67.4.1048.bloodjournal6741048.
Neog, Archana, Priyanka Singh, Sonu Kumar Gupta und Malkhey Verma. „miRNA-An Alternative Therapy for Chronic Myeloid Leukemia“. Asian Pacific Journal of Health Sciences 6, Nr. 1 (März 2019): 162–76. http://dx.doi.org/10.21276/apjhs.2019.6.1.24.
Pais, Anurita, Shailesh Pande, Gauri Pradhan, Akshay Tharali, Smita Patil und Chaitali Parab. „Acute Myeloid Leukemia with complex hyperdiploidkaryotypeA Case Report“. Annals of Pathology and Laboratory Medicine 2, Nr. 12 (17.12.2018): C185–189. http://dx.doi.org/10.21276/apalm.2299.
Kurtzberg, J., TA Waldmann, MP Davey, SH Bigner, JO Moore, MS Hershfield und BF Haynes. „CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells“. Blood 73, Nr. 2 (01.02.1989): 381–90. http://dx.doi.org/10.1182/blood.v73.2.381.381.
Kurtzberg, J., TA Waldmann, MP Davey, SH Bigner, JO Moore, MS Hershfield und BF Haynes. „CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells“. Blood 73, Nr. 2 (01.02.1989): 381–90. http://dx.doi.org/10.1182/blood.v73.2.381.bloodjournal732381.
Parasole, Rosanna, Laura Vicari, Fara Petruzziello, Anna Leszl, Giuseppe Menna, M. Tarsitano, Luigi Del Vecchio et al. „Trisomy of Chromosome 7: a Novel Cytogenetic Abnormality in a Paediatric Case of Mixed Acute Leukemia.“ Blood 114, Nr. 22 (20.11.2009): 4121. http://dx.doi.org/10.1182/blood.v114.22.4121.4121.
Oakley, Kevin, Yufen Han, Bandana A. Vishwakarma, Su Chu, Ravi Bhatia, Kristbjorn O. Gudmundsson, Jonathan Keller et al. „Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10“. Blood 119, Nr. 25 (21.06.2012): 6099–108. http://dx.doi.org/10.1182/blood-2011-10-388710.
Adamaki, Maria, Spiros Vlahopoulos, George I. Lambrou, Athanasios G. Papavassiliou und Maria Moschovi. „Aberrant AML1 gene expression in the diagnosis of childhood leukemias not characterized by AML1-involved cytogenetic abnormalities“. Tumor Biology 39, Nr. 3 (März 2017): 101042831769430. http://dx.doi.org/10.1177/1010428317694308.
Abdel-Wahab, Omar, und Ross L. Levine. „Metabolism and the leukemic stem cell“. Journal of Experimental Medicine 207, Nr. 4 (05.04.2010): 677–80. http://dx.doi.org/10.1084/jem.20100523.
Frankfurt, Olga, und Martin S. Tallman. „Growth Factors in Leukemia“. Journal of the National Comprehensive Cancer Network 5, Nr. 2 (Februar 2007): 203–15. http://dx.doi.org/10.6004/jnccn.2007.0020.
Shi, Yang, und Endi Wang. „Blastic Plasmacytoid Dendritic Cell Neoplasm: A Clinicopathologic Review“. Archives of Pathology & Laboratory Medicine 138, Nr. 4 (01.04.2014): 564–69. http://dx.doi.org/10.5858/arpa.2013-0101-rs.
Pavlova, T. Yu, und T. T. Valiev. „Priapism as the first symptom of chronic myeloid leukemia: literature review and own clinical case report“. Oncohematology 17, Nr. 4 (06.11.2022): 88–93. http://dx.doi.org/10.17650/1818-8346-2022-17-4-88-93.
Jianbiao Zhou, Jessie Yiying Quah, Yvonne Ng, Jing-Yuan Chooi, Sabrina Hui-Min Toh, Baohong Lin, Tuan Zea Tan et al. „ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia“. Haematologica 105, Nr. 9 (07.11.2019): 2286–97. http://dx.doi.org/10.3324/haematol.2019.230482.
Noll, Judit, Dorottya Asbóth, Judit Csomor, Mónika Csóka, Gábor Kovács, Gergely Kriván und Krisztián Kállay. „Newborn myeloid sarcoma“. Bőrgyógyászati és Venerológiai Szemle 96, Nr. 5 (21.10.2020): 257–60. http://dx.doi.org/10.7188/bvsz.2020.96.5.7.
Xiao, Zhijian, Yushu Hao und Shougeng Bian. „Acute myeloid leukemia M2B (subacute myeloid leukemia) in China“. Leukemia Research 21, Nr. 4 (April 1997): 351–52. http://dx.doi.org/10.1016/s0145-2126(96)00101-4.
Horton, Sarah J., Vanessa Walf-Vorderwülbecke, Steve J. Chatters, Neil J. Sebire, Jasper de Boer und Owen Williams. „Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities“. Blood 113, Nr. 20 (14.05.2009): 4922–29. http://dx.doi.org/10.1182/blood-2008-07-170480.
Konopleva, Marina, Elena Elstner, Teresa J. McQueen, Twee Tsao, Andrey Sudarikov, Wei Hu, Wendy D. Schober et al. „Peroxisome proliferator-activated receptor γ and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias“. Molecular Cancer Therapeutics 3, Nr. 10 (01.10.2004): 1249–62. http://dx.doi.org/10.1158/1535-7163.1249.3.10.
Saeed, Zabila. „Extramedullary Acute Myeloid Leukemia: Testicular Myeloid Leukemia, Leukemia Cutis with Leptomeningeal Involvement“. Blood 138, Supplement 1 (05.11.2021): 4376. http://dx.doi.org/10.1182/blood-2021-146659.
Kogan, Scott C., Suk-hyun Hong, David B. Shultz, Martin L. Privalsky und J. Michael Bishop. „Leukemia initiated by PMLRARα: the PML domain plays a critical role while retinoic acid–mediated transactivation is dispensable“. Blood 95, Nr. 5 (01.03.2000): 1541–50. http://dx.doi.org/10.1182/blood.v95.5.1541.005k28_1541_1550.
Smaldone, Giovanni, Luigi Coppola, Mariarosaria Incoronato, Rosanna Parasole, Mimmo Ripaldi, Luigi Vitagliano, Peppino Mirabelli und Marco Salvatore. „KCTD15 Protein Expression in Peripheral Blood and Acute Myeloid Leukemia“. Diagnostics 10, Nr. 6 (04.06.2020): 371. http://dx.doi.org/10.3390/diagnostics10060371.
Dinndorf, PA, und GH Reaman. „Acute lymphoblastic leukemia in infants: evidence for B cell origin of disease by use of monoclonal antibody phenotyping“. Blood 68, Nr. 4 (01.10.1986): 975–78. http://dx.doi.org/10.1182/blood.v68.4.975.975.
Dinndorf, PA, und GH Reaman. „Acute lymphoblastic leukemia in infants: evidence for B cell origin of disease by use of monoclonal antibody phenotyping“. Blood 68, Nr. 4 (01.10.1986): 975–78. http://dx.doi.org/10.1182/blood.v68.4.975.bloodjournal684975.
Matulonis, UA, C. Dosiou, C. Lamont, GJ Freeman, P. Mauch, LM Nadler und JD Griffin. „Role of B7-1 in mediating an immune response to myeloid leukemia cells“. Blood 85, Nr. 9 (01.05.1995): 2507–15. http://dx.doi.org/10.1182/blood.v85.9.2507.bloodjournal8592507.
Saglio, Giuseppe, Anna Serra, Anna Novarino, Michele Falda und Felice Gavosto. „N-Ras Mutations in Myeloid Leukemias“. Tumori Journal 75, Nr. 4 (August 1989): 337–40. http://dx.doi.org/10.1177/030089168907500407.
Fishman, Hila, Shreyas Madiwale, Ifat Geron, Vase Bari, Wouter Van Loocke, Yael Kirschenbaum, Itamar Ganmore et al. „ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells“. Blood 139, Nr. 3 (20.01.2022): 399–412. http://dx.doi.org/10.1182/blood.2020010405.
Miner, Samantha, Sawa Ito, Kazushi Tanimoto, Nancy F. Hensel, Fariba Chinian, Keyvan Keyvanfar, Christopher S. Hourigan et al. „Myeloid Leukemias Directly Suppress T Cell Proliferation Through STAT3 and Arginase Pathways“. Blood 122, Nr. 21 (15.11.2013): 3885. http://dx.doi.org/10.1182/blood.v122.21.3885.3885.
Lee, Po-Shing, Ching-Nan Lin, Chientzu Liu, Chien-Tai Huang und Wei-Shiou Hwang. „Acute Leukemia With Myeloid, B-, and Natural Killer Cell Differentiation“. Archives of Pathology & Laboratory Medicine 127, Nr. 2 (01.02.2003): e93-e95. http://dx.doi.org/10.5858/2003-127-e93-alwman.
Smith, Catherine C., und Neil P. Shah. „Mechanisms of Resistance to Targeted Therapies in Acute Myeloid Leukemia and Chronic Myeloid Leukemia“. American Society of Clinical Oncology Educational Book, Nr. 32 (Juni 2012): 685–89. http://dx.doi.org/10.14694/edbook_am.2012.32.103.
Heuser, Michael, Geyongsin Park, Ping Xiang, Sarah Vollett, Malina Leung, Courteney Lai, Grace Lin und R. Keith Humphries. „Microenvironment Determines Myeloid-Erythroid Lineage Switch in MN1 Leukemia“. Blood 112, Nr. 11 (16.11.2008): 2420. http://dx.doi.org/10.1182/blood.v112.11.2420.2420.
Walter, Roland B., Frederick R. Appelbaum, Elihu H. Estey und Irwin D. Bernstein. „Acute myeloid leukemia stem cells and CD33-targeted immunotherapy“. Blood 119, Nr. 26 (28.06.2012): 6198–208. http://dx.doi.org/10.1182/blood-2011-11-325050.